UKCP Briefing Note

AI in Therapy: Safe and Ethical Practice

Key insights and practical takeaways from the UKCP webinar

Source: UKCP_small.mp3 (full transcript, 658 segments) Duration: ~3h08m Speakers: 5 Prepared: 25 Sept 2026

01Overview

UKCP webinar bringing together four perspectives on AI in therapeutic practice: ethics and the therapeutic relationship, NHS clinical governance and systems risk, insurance and professional liability, and practical day-to-day decision-making for practitioners. Central thesis across all speakers: AI does not remove a practitioner's ethical responsibility, it relocates it. Every existing principle (confidentiality, competence, informed consent, therapeutic alliance) still applies, with an added layer of complexity.

SpeakerRoleFocus
Dr Helen MoldenHost — integrative psychotherapist & counselling psychologistFraming, Q&A moderation
Prof Elvira PerezProfessor of Mental Health & Digital Technology, University of NottinghamEthics: trust, transparency, consent, accountability
Dr Paul BradleyChief Clinical Information Officer, Hertfordshire Partnership University NHS Foundation TrustClinical safety, governance, regulation
Annie CavanaghClient Engagement Representative, Balens InsuranceInsurance and professional liability
Waseem Al-SarrajClinical psychologist & AI/mental health researcherPractical guidance, GUIDE decision framework, case studies

02By the Numbers

Speaking time and turns taken, by speaker

Floor time across the session

Derived from segment timestamps in the full transcript · total duration ~188 min · ~169.5 min of that was speech

Minutes speaking

Dr Paul Bradley
45.8m
Prof Elvira Perez
41.6m
Waseem Al-Sarraj
39.9m
Dr Helen Molden (Host)
32.0m
Annie Cavanagh
10.2m

Turns taken (segments)

Prof Elvira Perez
212
Waseem Al-Sarraj
161
Dr Paul Bradley
151
Dr Helen Molden (Host)
101
Annie Cavanagh
33
Dr Helen Molden
Prof Elvira Perez
Dr Paul Bradley
Annie Cavanagh
Waseem Al-Sarraj
Table view
SpeakerMinutes speakingSegments (turns)Share of speech
Dr Paul Bradley45.815127%
Prof Elvira Perez41.621225%
Waseem Al-Sarraj39.916124%
Dr Helen Molden (Host)32.010119%
Annie Cavanagh10.2336%

Reading note: Perez takes the most turns but Bradley holds the floor longest per turn — consistent with Bradley's talk running long-form (gardening/chainsaw analogies, NHS governance detail) versus Perez's more exchange-driven Q&A segment straight after her talk.

Key figures cited during the session

0%
of Americans surveyed already believe AI is conscious
Cited by Dr Paul Bradley
0
psychotherapists surveyed across 30 countries — most using ChatGPT with no formal training on it
Cited by Waseem Al-Sarraj
0
suppliers registered with the NHS's ambient scribe (AI note-taking) scheme
Cited by Dr Paul Bradley
0
people consulted for the National Commission on AI regulation report
Cited by Dr Paul Bradley
0%
of live webinar poll respondents said they use AI for research and learning
Live audience poll, Waseem Al-Sarraj's session
0–0mo
typical evidence-gathering period for an MHRA Class 2 medical device registration
Cited by Dr Paul Bradley

03Core Themes

Trust and transparency

Client trust in a practitioner breaks quickly if AI use is discovered undisclosed, and takes far longer to rebuild than it took to lose. Practitioners should be explicit and upfront about AI use before being asked, in plain language matched to the client's digital literacy. Shame around disclosing AI use (fear of being judged unprofessional by colleagues) was flagged as a live risk that itself needs addressing.

Consent as an ongoing conversation

Informed consent is not a one-time checkbox. It must be revisited as tools change, as practice evolves, and as public opinion (and therefore client attitudes) shifts. Clients must retain the right to decline AI use.

Data handling and confidentiality

Sycophancy, over-reliance and emerging risk concepts

LLMs are structurally biased toward agreement and engagement, not challenge, which creates specific clinical risk (e.g. a client citing AI validation to reject a therapist's clinical judgement or threaten complaint). New vocabulary surfaced during the session for tracking this over time:

TermMeaning
De-skilling / never-skilling / mis-skillingLosing an existing clinical skill through disuse; never developing it in the first place; or learning a distorted version of it via AI mediation
AI psychosisAI systems reinforcing grandiose, delusional or high-risk ideation through sycophantic responses
Therapeutic driftGradual erosion of clinical judgement and relational depth as AI mediates more of the clinical workflow
"LLMs as cognitive virus"Homogenising effect on language and thought from widespread use of aggregated, statistically-averaged AI output

Cultural bias

Large language models are trained predominantly on Western data and can misread or mishandle other cultural contexts. Flagged as an under-researched risk area, particularly relevant when clients use AI in a language or cultural frame the practitioner does not share.

Regulation and NHS governance

Insurance and accountability

AI-generated notes and summaries remain the practitioner's full professional responsibility. They must be reviewed and corrected before entering the clinical record; "the AI got it wrong" is not a viable defence in a complaint or claim. The standard UKCP/Balens policy does not include cyber liability cover (data breaches, hacking) by default — available as a separate add-on.

Embodiment and the "third in the room"

A recurring, unresolved question across all four speakers: what is lost when a machine becomes a third presence in the therapeutic relationship? Raised in relation to grief/companion bots, AI romantic relationships, digital "death tech" personas of the deceased, and smart-glasses/hologram technology. No consensus reached; flagged explicitly as ongoing research territory rather than a settled question.

"We used to be the cats. Now, we're the mice." Jill Lepore, quoted by Dr Helen Molden, opening framing metaphor for AI's disruption of human/bot trust

04Risk Stratification (Prof Perez)

LOWER RISK

  • AI used for psychoeducation, information, or between-session reflection
  • Used alongside therapy, not as a substitute for it
  • Client is open about their use, no sense of shame or secrecy
  • Client also draws on other sources of support, not AI alone

HIGHER RISK — requires active clinical attention

  • Used during moments of crisis or acute distress
  • Appears to be replacing the therapeutic alliance entirely
  • Client seeking diagnosis, medication dosage, or safety advice from AI (models are not trained for this)
  • Used with shame or in secrecy
  • Client is a minor or otherwise vulnerable/young person — additional safeguarding considerations apply

05The GUIDE Framework

Recently published, peer-reviewed decision framework (JMIR AI, "Navigating AI in Mental Healthcare") presented by Waseem Al-Sarraj as a practical tool for structuring decisions about AI use — applicable to patient-facing tools, clinician-facing systems, and shared digital therapeutics. Not a validated instrument or a fixed policy, but a structured way to slow down decision-making.

G

Gather

What is actually happening? What does the tool capture, how does it produce output, where does client information go? Test with a fictional case first if possible.

U

Understand

What does this mean for this specific client? Consider individual variation in comfort and need. Check whether meaning/nuance is preserved or lost.

I

Inform

Return to the client with a clear explanation of what the tool does and how data is handled. Discuss preferences, meet consent requirements, offer an alternative if declined.

D

Document

Record the discussion and the client's preference. Review and correct any AI-generated draft before it enters the clinical record, ensuring it reflects your own clinical judgement.

E

Evaluate

Step back periodically: is it saving time, preserving meaning, and supporting judgement — or introducing errors, de-skilling, or reducing client openness?

06Responding When a Client Brings AI Into the Room

Practical guidance, consolidated from Prof Perez's and Waseem Al-Sarraj's sessions:

07Action Points for Practice

  1. Create a simple, written AI use checklist/charter: which tools are used, why, and what for.
  2. Check and document the privacy/security terms of any AI tool before adoption — encryption, data residency, opt-out of training use.
  3. Agree a consistent, plain-language consent script if working within a team or organisation.
  4. Set a defined escalation route for AI-related risk disclosures (crisis use, dependency, misinformation).
  5. Never upload identifiable client information to any AI tool, under any circumstance.
  6. Review and correct any AI-generated notes before filing — full clinical accountability remains with the practitioner.
  7. Revisit the checklist and consent conversations periodically — this is a fast-moving area, not a static policy.
  8. Check whether cyber liability cover is needed in addition to standard professional indemnity insurance.
  9. If NHS-affiliated: confirm local organisational approval before adopting any new AI tool — "NHS approved" is not a valid claim on its own.

08Resources Mentioned

09Closing Reflections

Repeated, independently, by three of the four speakers: a real risk of a two-tier future where human therapists become accessible mainly to those who can pay, and AI-only support becomes the default for everyone else. All three clinical speakers converged on the same bottom line, echoing the APA/BPS consensus position: AI should augment clinical judgement, never substitute for it. The single largest unresolved tension named across the session is that AI tools are being deployed into mental health practice at scale with essentially no long-term evidence base or clinical trial data behind them.